Abstract: Lead (Pb) is one of the most important heavy metals that possess many applications in different kinds of industrial procedures and consumer products. The adverse effects of Pb on different parts of the immune system have been reported in various studies. Although it has been shown that high concentrations of Pb have low cytotoxicity on human lymphocytes, the effects of non-cytotoxic concentrations of Pb (detected in human blood) on cellular organelles and oxidative stress factors of human lymphocytes have yet to be determined. In this study, human lymphocytes were obtained from the blood of healthy male volunteers through the use of the Ficoll standard method. The intention of this paper was to determine the effects of non-cytotoxic concentrations of Pb on human lymphocytes using the accelerated cytotoxicity mechanism screening technique. For determination of cell viability, lymphocytes were treated with 0-1 mm Pb for 12 h. Subsequently, we assayed the effects of non-cytotoxic concentrations of Pb which are detected in human blood on human lymphocytes and investigated if Pb can affect oxidative stress and cellular organelles at these concentrations. So, in concentrations which have no cytotoxic effects, Pb is shown to induce oxidative stress in addition to inflicting damage on mitochondria and lysosomes in human blood lymphocytes.
Introduction
Despite toxic effects of lead (Pb) on biological systems and the environment, the metal has been used in different industrial processes. Pb disrupts biological systems by changing cell signaling, cell function and enzyme activities (Dietert and Piepenbrink, 2006; Counter et al., 2009) . Although Pb has been categorized as possibly carcinogenic to humans by the International Agency for Research on Cancer (IARC, 1987) , the metal is present in some types of batteries, different kinds of paint products, tableware (crystal and pottery), hair dye products and ammunitions. Apart from the environmental exposure to Pb, exposure to Pb in the workplace has been a concern.
Immune system sensitivity to Pb exposure gives rise to a great concern about the immunotoxicity of Pb in humans (Burger and Gochfeld, 2000) . Although the exact mechanism by which Pb affects the immune system still remains unknown, some adverse effects have been reported. In animal studies, Pb has been demonstrated to affect macrophages (Tian and Lawrence, 1995; Chen et al., 1997) and T cells (McCabe and Lawrence, 1991; Guo et al., 1996) with low-moderate levels of exposure (Zelikoff et al., 1994) . The most sensitive target cells are CD4 + T cells subpopulation (McCabe et al., 2001) . Changes in immune functions have also been reported (Chen et al., 2004a; Luebke et al., 2006) . Some studies indicated that Pb exposure influences the immune response, impairing the lymphocyte's function and production of cytokine (Dyatlov and Lawrence, 2002; Chen et al., 2004b) , changing the ratio of lymphocyte subpopulation (Mishra, 2009) , release of immunoglobulins (Dietert and Piepenbrink, 2006) and antibody production (Koller, 1973; Koller and Kovacic, 1974) . The effects of Pb on immune functions have an association with a reduction of host resistance against tumor cells and infectious agents. Numerous researches in a variety of species have reported enhanced disease susceptibility following exposure to Pb. These comprise increased susceptibility to viral infection (Gupta et al., 2002) , bacterial agents (Kowolenko et al., 1991; Dyatlov and Lawrence, 2002) , cancer (Kobayashi and Okamoto, 1974; Kerkvliet and Baecher-Steppan, 1982) and autoimmune disease (Hudson et al., 2003) .
In occupationally exposed workers, Pb-associated alterations have been reported for the response of T-cells to mitogens (Mishra et al., 2003) , subpopulation of T-cells (Pinkerton et al., 1998; Sata et al., 1998) and serum levels of immunoglobulins or complement factors (Ewers et al., 1982; Anetor and Adeniyi, 1997) . Previously reported studies demonstrated selective changes in some parameters of estrogen action following acute, subacute, or chronic (Tchernitchin et al., 2003) exposure to Pb, which can be additionally explained partly by hematologic changes caused by Pb (Villagra et al., 1997) . So far, a few studies have assayed the effects of Pb on human lymphocytes and most of the results are inconclusive. Although it has been shown that high concentrations of Pb have low cytotoxicity on human lymphocytes, the effects of noncytotoxic concentrations of Pb (found in human blood) on cellular organelles and oxidative stress factors of human lymphocytes have yet to be characterized. Our results demonstrate that non-cytotoxic concentrations of Pb have toxic effects on human lymphocytes within 6 h treatment. These adverse effects include: altering factors which are related to oxidative stress and inflicting changes in different cell organelles. Such effects can finally lead to changes in immune system responses.
Results

Cell viability
For the cell viability test, we employed a range of Pb concentrations which have previously been used in different in vitro researches about toxicity of Pb. As shown in Figure 1 , following treatment of human lymphocytes with different concentrations of Pb for 12 h, no cytotoxic effect was observed. Therefore, we chose non-cytotoxic concentrations which had been detected in human blood for performing other tests in this study (Figure 1 ).
Reactive oxygen species
2′,7′-dichlorofluorescein diacetate (DCFH-DA) was used for measurement of reactive oxygen species (ROS). After treatment of lymphocytes with different concentrations of Pb, generation of ROS was assessed, and as illustrated in Figure 2 , Pb induced oxidative stress at 4 h and 6 h after beginning treatment. ROS formation was significant (p < 0.05) with concentration 1 μm at 4 h and with all concentrations at 6 h in comparison to the control (Figure 2 ).
Mitochondrial membrane potential
Mitochondrial membrane potential (MMP) as an indicator of mitochondrial damage was measured 2 h, 4 h and 6 h after treatment of human lymphocytes with Pb. Pb reduced MMP in a time-dependent manner and with passing time, the reduction of MMP increased. As shown in Figure 3 , Pb significantly (p < 0.05) reduced MMP with a concentration of 1 μm at 2 h, with concentrations of 0.5 μm and 1 μm at 4 h and with all concentrations at 6 h 
Lipid peroxidation
Malondialdehyde (MDA) is one of the final products of lipid peroxidation that show cell membrane damage following oxidative stress. After treatment of human lymphocytes with Pb acetate, an increase in MDA was observed.
As shown in Figure 4 , the increase in MDA was significant (p < 0.05) at 6 h at all concentrations in comparison to the control and increase of MDA at 2 h and 4 h was not significant (p < 0.05) ( Figure 4 ).
Lysosomal membrane leakage
Redistribution of acridine orange was used as an indicator for assessment of lysosomal membrane destabilization. As shown in Figure 5 , leakage of lysosomal membrane began 4 h after treatment with Pb acetate. Leakage of lysosomal membrane was significant (p < 0.05) with 1 μm at 4 h and Collapse in mitochondrial membrane potential assayed using rhodamine 123 after 2 h, 4 h and 6 h treatment with Pb. Pb significantly (p < 0.05) reduced mitochondrial membrane potential at a concentration of 1 μm at 4 h and at concentrations of 0.5 μm and 1 μm at 6 h in comparison to the control. Cyclosporine A, one of the blockers of mitochondrial permeability transition (MPT), inhibited this decrease in mitochondrial membrane potential. Bars/whiskers, respectively, represent mean/standard error and p values related to two way analysis of variance. *p < 0.05, **p < 0.01 and ***p < 0.001. Leakage of lysosomal membranes starts 4 h after treatment with Pb acetate. Increase in leakage of lysosomal membranes was significant (p < 0.05) at 1 μm at 4 h and at 0.1 μm, 0.5 μm and 1 μm at 6 h and pretreatment with 100 μm chloroquine inhibited destabilization of lysosomal membrane after treatment with Pb acetate. Bars/ whiskers, respectively, represent mean/standard error and p values related to two way analysis of variance. *p < 0.05, **p < 0.01 and ***p < 0.001.
with 0.1 μm, 0.5 μm and 1 μm at 6 h time intervals. Pretreatment of lymphocytes with 100 μm chloroquine inhibited the leakage of lysosomal membranes after treatment with Pb acetate (Figure 5 ).
Glutathione and oxidized glutathione
We measured the glutathione (GSH) and oxidized glutathione (GSSG) levels in human lymphocytes obtained from healthy individuals after incubation with Pb acetate. Treatment of human lymphocytes with Pb caused a statistically significant (p < 0.05) collapse in GSH content; this collapse occurred with 1 μm at 2 h, 0.5 μm and 1 μm at 4 h and with all concentrations at 6 h in comparison to the control. At all of these times, GSSG concentration significantly (p < 0.05) increased in human lymphocytes following treatment with Pb ( Figure 6 ).
Discussion
It has been suggested that one of the most important targets of Pb toxicity is the immune system and different parts of the immune system are influenced. It has been shown that inhibition of the humoral immune response by Pb leads to the generation of a lower level of antibodies (Koller, 1973) . Ewers et al. (1982) reported that in Pbexposed workers with blood Pb levels of 21-90 μg/dL, more cold and influenza infections per year, and a significant suppression of the level of antibodies occurred. Koller et al. (1979) demonstrated that Pb suppressed lymphocyte proliferation stimulated by lipopolysaccharide in mice. Such an effect has also been reported in lymphocytes isolated from Pb-exposed workers (Alomran and Shleamoon, 1988) . The aim of this study was to investigate the mechanisms that contribute to adverse effects of non-cytotoxic concentrations of Pb in human lymphocytes. Preliminary evaluation measured the cytotoxic effect of Pb on human lymphocytes. Following treatment of human lymphocytes with concentrations up to 1000 μm for 12 h, no significant decrease in cell viability was observed. Our results are in accordance with studies which assayed Pb cytotoxicity on human lymphocytes. Steffensen et al. (1994) investigated the cytotoxic effects of different metals on human peripheral T and B lymphocytes and monocytes in vitro. They observed a weak cytotoxic effect after 3-4 days exposure to 1000 μm. In another study, Portales-Pérez et al. (2002) showed that Pb did not induce apoptosis of MNC, even at a very high concentration (500 μm).
A significant (p < 0.05) increase in ROS was observed after incubation of human lymphocytes with Pb acetate. Fracasso et al. (2002) monitored the change in ROS production in lymphocytes from exposed workers and an unexposed group and showed that ROS production was significantly higher in exposed workers than the unexposed group. They also assayed the GSH levels in lymphocytes and demonstrated that the levels in lymphocytes from workers were dramatically low compared to the unexposed group. Pb exposure decreased the GSH levels and this loss was not due to the years of employment but depended on blood levels of Pb (Fracasso et al., 2002) . In accordance with Fracasso's study, we also demonstrate that Pb reduces GSH levels and increases GSSG levels in human lymphocytes. Chen et al. (2004a,b) Time after treatment with Pb The effect of Pb acetate on glutathione (GSH) and GSSG. GSH and GSSG measured in accordance with Hissin and Hilf methods 2 h, 4 h and 6 h after treatment with Pb. Pb caused significant (p < 0.05) GSH depletion (A) and increase in GSSG (B) in human lymphocytes. Bars/whiskers, respectively, represent mean/standard error and p values are related to two way analysis of variance. *p < 0.05, **p < 0.01 and ***p < 0.001. investigated the effect of Pb on PC12 cells. A remarkable increase in intracellular GSSG and decrease in GSH levels was reported. Pb has the ability of sharing electrons and forming covalent binding. This covalent binding attaches to sulfhydryl groups of antioxidant enzymes and may lead to inactivation of these enzymes. Pb also inactivates GSH through binding to its sulfhydryl groups. This event leads to synthesis of GSH through alternative pathways that usually are ineffective in replacement of GSH (Hultberg et al., 2001) . Pb decreases GSH levels further by inactivation of enzymes include GSH reductase, GSH peroxidase, GSH-S-transferase and δ-amino levulinic acid dehydratase (Ahamed and Siddiqui, 2007) .
Oxidative stress finally leads to lipid peroxidation, which is one of the most important consequences of ROS production. Sivaprasad et al. (2004) demonstrated that Pb causes lipid peroxidation in the liver, lungs, heart and kidneys of Pb-exposed animals. There was a significant (p < 0.001) increase in the lipid peroxidation and a decrease in the levels of endogenous antioxidants (Upasani and Balaraman, 2003) . In another study, Pb acetate was added to the drinking water of albino rat for 5 weeks and significant induction of lipid peroxidation was observed in the liver (Sivaprasad et al., 2004) . Our study shows that Pb can cause lipid peroxidation in human lymphocytes after 6 h of treatment.
Mitochondria are important organelles in the generation of cell energy; they also have a key role in cell survival and death. It has been reported that Pb can decrease MMP in PC12 cells (Chen et al., 2003) . We also show that Pb causes MMP collapse in human lymphocytes. Cyclosporine A, one of the blockers of MPT, inhibits collapse of MMP after treatment of human lymphocytes with Pb acetate. MMP collapse may cause the release of cytochrome c from mitochondria, which can trigger cellular death through apoptosis or necrosis.
Our study shows that Pb can cause lysosomal membrane destabilization in human lymphocytes. When lymphocytes were preloaded with acridine orange, redistribution of acridine orange from lysosome to the cytosolic fraction happened after 6 h. Association of Pb toxicity with lysosomal injury was also demonstrated through prevention of Pb-induced leakage of lysosomal membrane by chloroquine. Orsi et al. (1987) report that the exposure of cells to Pb can causes delayed destabilization of the lysosomal membrane and leakage of acridine orange. Pb-induced oxidative stress and lipid peroxidation may lead to leakage of lysosomal membranes and the release of lysosomal proteases. It has been reported that lysosomal proteases may activate caspases and cause cell death (Turk et al., 2000) .
Conclusion
We observed that non-cytotoxic concentrations of Pb, which have been detected in human blood, can induce oxidative stress in human lymphocytes. Pb changes GSH and GSSG levels through the induction of oxidative stress, and furthermore triggers lipid peroxidation. Pb also affects lymphocytes organelles such as mitochondria, which have an important role in cell survival and death. Only 6 h following treatment of human lymphocytes with Pb, reduction of lysosomal membrane integrity was observed. Prevention of Pb-induced leakage of lysosomal membranes by chloroquine shows an association between Pb toxicity and lysosomal injury. This study concludes that non-cytotoxic concentrations of Pb can have toxic effects on human lymphocytes and as a result, change the immune system response.
Experimental section Chemicals
Trypan blue, DCFH-DA, rhodamine 123, bovine serum albumin, acridine orange, o-phthalaldehyde, N-ethylmaleimide, Pb acetate and trichloroacetic acid were purchased from Sigma-Aldrich Co. (Taufkirchen, Germany). RPMI1640 and fetal bovine serum (FBS) were purchased from Gibco, Life Technologies (Grand Island, NY, USA). Ficoll-Paque PLUS was obtained from Ge Healthcare Bio-Science Company (Chicago, IL, USA).
Ethics statement
This study was performed at Shahid Beheshti University of Medical Sciences (SBMU) at the Faculty of Pharmacy and approved by the research Ethics Committee of SBMU (Number: IR.SBMU.RAM. REC.1395.7; date: April 10, 2016). All study participants gave their consent and signed a consent form.
Isolation and treatment of lymphocytes isolated from human blood
Blood samples were derived from 10 healthy, nonsmoking volunteers (between the ages of 18 and 30 years old). The volunteers had not taken any immune modulating drugs and did not exhibit any symptoms of infectious disease at the time of blood sample collection. A total volume of 5 mL of heparinized blood was diluted with 5 mL phosphate buffer saline (PBS) and slowly poured on 3 mL FicollPaque and centrifuged for 20 min at 2500 rpm. The plasma layer was removed slowly and the white color layer containing human lymphocytes was suspended in erythrocyte lysis buffer (150 mm NH 4 Cl, 10 mm NaHCO 3 , 1 mm EDTA, pH 7.4). Cells were incubated for 5 min at 37°C. Subsequently, 10 mL PBS was added to a tube, centrifuged at 1500 rpm, and the supernatant was removed. Cells were then washed twice with RPMI1640 containing 10% FBS at 2000 g for 7 min and 1-1.5 × 10 6 cells were diluted in 1 mL of RPMI1640 containing 10% FBS and 1% antibiotic (penstrep) for use in a different test. Cytotoxicity was measured after treatment of lymphocytes with 50-1000 μm Pb for 12 h. Cells were treated with 0.1 μm, 0.5 μm and 1 μm of Pb for 2 h, 4 h and 6 h for further tests.
Cell viability assay
The cytotoxicity test was performed using trypan blue exclusion dye, which can penetrate membranes of dead cells and color them blue, and the MTT assay. For measurement of cell viability using trypan blue, cells were cultured in 96-well plates in a concentration of 1 × 10 4 cells per well and treated with different concentrations of Pb acetate for 12 h. An equal volume of cell suspension in addition to trypan blue 0.4% was mixed. Subsequently, the numbers of live and dead cells were counted using a light microscope and a hemocytometer and EC50s were calculated. For the MTT assay, at the end of the treatment, 10 mL of 12 mm MTT stock solution was added to each well and incubated for an additional 4 h at 37°C. The purple-blue MTT formazan precipitate was dissolved in 100 μL of DMSO, and the absorbance was measured at 570 nm with an ELISA reader.
Measurement of ROS
DCFH-DA was used for assessment of ROS. Cellular esterase breaks down DCFH-DA to non-fluorescent DCFH and the reaction of ROS with DCFH produces fluorescent DCF. Human lymphocytes were treated for 2 h, 4 h and 6 h with different concentrations of Pb. Subsequently, cells were incubated with 500 μL of 10 μm DCFH-DA solution for 20 min at 37°C. Finally, cells were washed with PBS and fluorescence intensity was measured with a fluorescence spectrophotometer (Shimadzu RF5000U, Nishinokyo-Kuwabaracho, Nakagyo-ku, Kyoto, Japan) at 495 nm and 530 nm excitation and emission wavelength (Pourahmad et al., 2011b) .
Assessment of MMP
MMP was assessed at 2 h, 4 h and 6 h after treatment of cells with different concentrations of Pb using rhodamine 123, which can concentrate in the mitochondria of live cells (active mitochondria). After removal of the supernatant by centrifuging at 1000 g for 5 min, 500 μL of 5 μm rhodamine 123 was added to the cell suspension and incubated for 10 min. Fluorescence of rhodamine 123 was measured at 470 nm excitation and 540 nm emission wavelength using a fluorescence spectrophotometer (Shimadzu RF5000U) (Pourahmad et al., 2009 ).
Lipid peroxidation measurement
Lipid peroxidation was assessed based on the reaction of thiobarbituric acid (TBA) and MDA (one of the lipid peroxidation products). Following treatment of human lymphocytes with different concentrations of Pb, cells were lysed with PBS containing 2% Triton. Some 200 μL TBA reagent (TBA 0.37%, trichloroacetic acid 15% and HCl 2.5 n) were added to 100 μL of cells and heated in hot water (90°C) for 60 min. Fluorescence was measured by a fluorescence spectrophotometer (Shimadzu RF5000U) with 544 nm and 590 nm excitation and emission wavelengths and concentrations of TBA-MDA were measured using the calibration curve of the TBA-MDA (Wasowicz et al., 1993) .
Assessment of lysosomal membrane destabilization
Acridine orange is a lipophilic dye that enters acidic organelles of cells such as lysosomes. Upon damage to the lysosomal membrane, the dye diffuses from that organelle. This lipophilic dye was used for assessment of lysosomal membrane destabilization. After treatment of human lymphocytes with Pb, lysosomal membrane destabilization was measured during 2 h, 4 h and 6 h time intervals. Some 100 μL of 5 μm acridine orange was added to 100 μL of cell suspension and incubated for 10 min in 37°C. Lymphocytes were washed and the fluorescence of diffused acridine orange was assessed at 470 nm and 540 nm excitation and emission wavelengths by a fluorescence spectrophotometer (Pourahmad et al., 2011a) .
GSH and GSSG assessment
To measure oxidized and reduced glutathione, the Hissin and Hilf (1976) method was used with some modification. Human lymphocytes with different concentrations of Pb were incubated at 2 h, 4 h and 6 h time intervals. Cells were lysed with 0.5 mL of 10% trichloroacetic acid. Lymphocytes were centrifuged at 11,000 rpm for 2 min. For GSH determination, cell supernatants were diluted with phosphate-EDTA buffer and incubated with 100 μL of the orthophthaldehyde (OPT) solution for 15 min at room temperature. For measurement of GSSG, lymphocyte supernatant was diluted with 0.1 n NaOH solution, and prior to the addition of OPT, 200 μL of N-ethylmaleimide solution was incubated with diluted supernatant for 30 min. Finally, fluorescence intensity was determined at 350 nm and 420 nm excitation and emission wavelengths, and GSH and GSSG calibration curves were used for the calculation of GSH and GSSG concentration (Hissin and Hilf, 1976) .
Statistical analysis
At least three independent experiments were used for statistical analyses of data and normal (Gaussian) distribution was assessed. Data were analyzed using one-way and two-way analysis of variance followed by post hoc Tukey and Bonferroni tests by GraphPad Prism 5 (Graphpad Software, La Jolla, CA, USA). A p value <0.05 was considered statistically significant. Results were expressed as mean ± standard error.
